MTNB
Matinas Biopharma Holdings, Inc. Common Stock (MTNB)
$59
About Matinas Biopharma Holdings, Inc. Common Stock (MTNB)
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.
Details
Daily high
$0.62
Daily low
$0.56
Price at open
$0.56
52 Week High
$3.09
52 Week Low
$0.47
Market cap
3.8M
Dividend yield
0.00%
Volume
15,130
Avg. volume
46,907
P/E ratio
-.17
Matinas Biopharma Holdings, Inc. Common Stock News
Details
Daily high
$0.62
Daily low
$0.56
Price at open
$0.56
52 Week High
$3.09
52 Week Low
$0.47
Market cap
3.8M
Dividend yield
0.00%
Volume
15,130
Avg. volume
46,907
P/E ratio
-.17